The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Neurotransmitter deficits from frontotemporal lobar degeneration
Open accessAbstract
Frontotemporal lobar degeneration causes a spectrum of complex degenerative disorders including frontotemporal dementia, progressive supranuclear palsy and corticobasal syndrome, each of which is associated with changes in the principal neurotransmitter systems. We review the evidence for these neurochemical changes and propose that they contribute to symptomatology of frontotemporal lobar degeneration, over and above neuronal loss and atrophy. Despite the development of disease-modifying therapies, aiming to slow neuropathological progression, it remains important to advance symptomatic treatments to reduce the disease burden and improve patients' and carers' quality of life. We propose that targeting the selective deficiencies in neurotransmitter systems, including dopamine, noradrenaline, serotonin, acetylcholine, glutamate and gamma-aminobutyric acid is an important strategy towards this goal. We summarize the current evidence-base for pharmacological treatments and suggest strategies to improve the development of new, effective pharmacological treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221
Aston-Jones, G., & Cohen, J. D. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135709 · Cited by 4,472
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379 · cited 1×
“Loss of dopaminergic neurons in the nigrostriatal pathway causes parkinsonism in Parkinson’s disease, but also in FTLD. Additional mesolimbic and meso-cortical dopaminergic neurons from the ventral tegmental area regulate reward, learning and motivation-related behaviour (Wise, 2004).”
Mechanisms of Gamma Oscillations
Buzsáki, G., & Wang, X.-J. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150444 · Cited by 2,796
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Canonical Microcircuits for Predictive Coding
Bastos, A. M., Usrey, W. M., Adams, R. A., Mangun, G. R., Fries, P., & Friston, K. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.10.038 · Cited by 2,421 · cited 2×
“The GABA–glutamate interaction is of particular relevance because it supports precisely tuned oscillatory dynamics of neural circuits for cognition (Bastos et al. , 2012).”
The cholinergic hypothesis of Alzheimer’s disease: A review of progress
Francis, P. T., Palmer, A. M., Snape, M., & Wilcock, G. K. (1999) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.66.2.137 · Cited by 2,198 · cited 1×
“The loss of cholinergic neurons and reduced choline acetyltransferase in Alzheimer’s disease (Francis et al. , 1999) lies behind the widespread use of cholinesterase inhibitors to enhance cholinergic transmission and thereby alleviate cognitive symptoms in Alzheimer’s disease (Rogers et al. , 1998).”
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070
Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., et al. (2006) · Nature · doi:10.1038/nature05016 · Cited by 2,058
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f0fd1 · Cited by 1,904
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848
Neuronal gamma-band synchronization as a fundamental process in cortical computation
Fries, P. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135603 · Cited by 1,713
CENTRAL CHOLINERGIC SYSTEMS AND COGNITION
Everitt, B. J., & Robbins, T. W. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.649 · Cited by 1,348
Long story short: the serotonin transporter in emotion regulation and social cognition
Canli, T., & Lesch, K.-P. (2007) · Nature Neuroscience · doi:10.1038/nn1964 · Cited by 1,034
Mackenzie, I. R. A., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. G., Ghetti, B., Halliday, G., Holm, I. E., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0612-2 · Cited by 1,012 · cited 18×
“We therefore anticipate that clinical trials of CBS will stratify treatment according to biomarkers, such as amyloid PET imaging or CSF, to distinguish CBD from Alzheimer’s disease aetiology.”
InfluentialThe human raphe nuclei and the serotonergic system
Hornung, J.-P. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2003.10.002 · Cited by 742 · cited 2×
“The caudal group project mainly to the brainstem and spinal cord (Hornung, 2003).”
Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain
Selden, N. (1998) · Brain · doi:10.1093/brain/121.12.2249 · Cited by 657 · cited 1×
“5A) (Selden, 1998).”
Clinical, genetic and pathological heterogeneity of frontotemporal dementia: A review
Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A. L., Fox, N. C., & van Swieten, J. C. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.212225 · Cited by 609
Organization of the Locus Coeruleus-Norepinephrine System
Schwarz, L. A., & Luo, L. (2015) · Current Biology · doi:10.1016/j.cub.2015.09.039 · Cited by 578
Wang, M., Yang, Y., Wang, C.-J., Gamo, N. J., Jin, L. E., Mazer, J. A., Morrison, J. H., Wang, X.-J., & Arnsten, A. F. T. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.032 · Cited by 489 · cited 1×
“For example, NMDA receptors in the hippocampus regulate long term potentiation (Morris et al. , 1986; Rowland et al. , 2005) while sustained activation of the dorsolateral prefrontal cortex during working memory requires NMDA stimulation (Wang et al. , 2013).”
Serotonin modulation of cortical neurons and networks
Celada, P., Puig, M. V., & Artigas, F. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00025 · Cited by 462 · cited 1×
“Serotonin has important roles in synaptic plasticity and as a neuromodu-lator of the direct effects of other neurotransmitters (Celada et al. , 2013).”
Pathologic heterogeneity in clinically diagnosed corticobasal degeneration
Boeve, B. F., Maraganore, D. M., Parisi, J. E., Ahlskog, J. E., Graff-Radford, N., Caselli, R. J., Dickson, D. W., Kokmen, E., & Petersen, R. C. (1999) · Neurology · doi:10.1212/wnl.53.4.795 · Cited by 417
Neuropathology of variants of progressive supranuclear palsy
Dickson, D. W., Ahmed, Z., Algom, A. A., Tsuboi, Y., & Josephs, K. A. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32833be924 · Cited by 386 · cited 1×
“3C) (Hauw et al. , 1994; Mori et al. , 2002; Dickson et al. , 2010).”
Robinson, E. S. J., Eagle, D. M., Mar, A. C., Bari, A., Banerjee, G., Jiang, X., Dalley, J. W., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301487 · Cited by 359
Broca's Region: Novel Organizational Principles and Multiple Receptor Mapping
Amunts, K., Lenzen, M., Friederici, A. D., Schleicher, A., Morosan, P., Palomero-Gallagher, N., & Zilles, K. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000489 · Cited by 357 · cited 1×
“This is relevant in view of the evidence that the frontotemporal language networks of a healthy brain receive significant cholinergic inputs (Amunts et al. , 2010).”
Heterogeneous organization of the locus coeruleus projections to prefrontal and motor cortices
Chandler, D. J., Gao, W.-J., & Waterhouse, B. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320827111 · Cited by 341
Porcelli, S., Fabbri, C., & Serretti, A. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.10.003 · Cited by 331 · cited 2×
“To add to this complexity, genetic polymorphisms within a receptor subtype (Barnes and Sharp, 1999) and presynaptic transporter (Porcelli et al., 2012), influence serotonergic function.”
Free Energy, Precision and Learning: The Role of Cholinergic Neuromodulation
Moran, R. J., Campo, P., Symmonds, M., Stephan, K. E., Dolan, R. J., & Friston, K. J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4255-12.2013 · Cited by 312
A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia
Huey, E. D., Putnam, K. T., & Grafman, J. (2006) · Neurology · doi:10.1212/01.wnl.0000191304.55196.4d · Cited by 299 · cited 6×
“Reductions in serotonin transmission or postsynaptic receptor densities are associated with several symptoms seen in FTD including aggression, impulsivity, increased appetite and depression (Huey et al., 2006).”
InfluentialPreliminary Findings: Behavioral Worsening on Donepezil in Patients With Frontotemporal Dementia
Mendez, M. F., Shapira, J. S., McMurtray, A., & Licht, E. (2007) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000231744.69631.33 · Cited by 267 · cited 1×
“In contrast bvFTD patients taking donepezil had worsening disinhibition and compulsive behaviour (Mendez et al. , 2007).”
CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Skillbäck, T., Farahmand, B., Bartlett, J. W., Rosén, C., Mattsson, N., Nägga, K., Kilander, L., Religa, D., Wimo, A., Winblad, B., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000001015 · Cited by 263 · cited 2×
“…et al. , 2017), genetic association (Seelaar et al. , 2011; Baizabal-Carvallo and Jankovic, 2016), pathology (MacKenzie et al. , 2010), and clinical and imaging biomarkers (Whitwell et al. , 2005; Hughes et al. , 2013; Skillback et al. , 2014; Rohrer et al. , 2015 b ; Ranasinghe et al. , 2016).”
Boxer, A. L., Knopman, D. S., Kaufer, D. I., Grossman, M., Onyike, C., Graf-Radford, N., Mendez, M., Kerwin, D., Lerner, A., Wu, C.-K., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70320-4 · Cited by 228
McGaughy, J., Ross, R. S., & Eichenbaum, H. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.064 · Cited by 226 · cited 1×
“These noradrenergic pathways have an important role in regulating the function of the prefrontal cortex (McGaughy et al. , 2008; Chandler et al. , 2014), while in contrast to dopamine, there is minimal noradrenergic innervation of the striatum.”
Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia
Kertesz, A., Morlog, D., Light, M., Blair, M., Davidson, W., Jesso, S., & Brashear, R. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000113034 · Cited by 217 · cited 1×
“A randomized, double-blind trial of galantamine versus placebo found no effect on cognitive function or activities of daily living (Kertesz et al. , 2008).”
Ranasinghe, K. G., Rankin, K. P., Pressman, P. S., Perry, D. C., Lobach, I. V., Seeley, W. W., Coppola, G., Karydas, A. M., Grinberg, L. T., Shany-Ur, T., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2016 · Cited by 151
An in vivo assay of synaptic function mediating human cognition
Moran, R. J., Symmonds, M., Stephan, K. E., Friston, K. J., & Dolan, R. J. (2011) · Current Biology · doi:10.1016/j.cub.2011.06.053 · Cited by 137
Newman, L. A., Darling, J., & McGaughy, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1097-8 · Cited by 137
Parkinsonism, movement disorders and genetics in frontotemporal dementia
Baizabal-Carvallo, J. F., & Jankovic, J. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.14 · Cited by 121
Improving response inhibition systems in frontotemporal dementia with citalopram
Hughes, L. E., Rittman, T., Regenthal, R., Robbins, T. W., & Rowe, J. B. (2015) · Brain · doi:10.1093/brain/awv133 · Cited by 100 · cited 5×
“In bvFTD there are reduced neurophysiological markers of inhibitory control and prefrontal cortical function, which are restored with the selective serotonin reuptake inhibitor cita-lopram in a placebo-controlled double-blind assessment (Hughes et al. , 2015).”
InfluentialSelf-citationGorelova, N., Mulholland, P. J., Chandler, L. J., & Seamans, J. K. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr107 · Cited by 98
Seppi, K., Scherfler, C., Donnemiller, E., Virgolini, I., Schocke, M. F. H., Goebel, G., Mair, K. J., Boesch, S., Brenneis, C., Wenning, G. K., et al. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.1154 · Cited by 64
Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy
Hughes, L. E., Ghosh, B. C. P., & Rowe, J. B. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.03.009 · Cited by 60
Self-citationVermeiren, Y., Le Bastard, N., Van Hemelrijck, A., Drinkenburg, W. H., Engelborghs, S., & De Deyn, P. P. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.06.010 · Cited by 56 · cited 3×
“1E), while CSF levels of dopamine and its metabolites are reduced in some (Sjogren et al. , 1998) but not all studies (Vermeiren et al. , 2013).”
C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism
O'Dowd, S., Curtin, D., Waite, A. J., Roberts, K., Pender, N., Reid, V., O'Connell, M., Williams, N. M., Morris, H. R., Traynor, B. J., et al. (2012) · Movement Disorders · doi:10.1002/mds.25022 · Cited by 52 · cited 1×
“…in the C9orf72 gene on chromosome 9 is most typically associated with FTD with amyotrophic lateral sclerosis (Rohrer et al. , 2015 a ), but up to half of patients have parkinsonism, with decreased dopamine transporter levels in the basal ganglia (Boeve et al. , 2012; O’Dowd et al. , 2012).”
Extrapyramidal symptoms in frontotemporal dementia: prevalence and clinical correlations
Padovani, A., Agosti, C., Premi, E., Bellelli, G., & Borroni, B. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.05.049 · Cited by 46
Sedaghat, F., Gotzamani-Psarrakou, A., Dedousi, E., Arnaoutoglou, M., Psarrakos, K., Baloyannis, I., Dimitriadis, A. S., & Baloyannis, S. J. (2007) · Neurodegenerative Diseases · doi:10.1159/000105159 · Cited by 30
Cholinergic and peptidergic systems in PSP
Javoy-Agid, F. (1994) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-6641-3_16 · Cited by 23
Rowe, J. B., Saunders, J. R., Durantou, F., & Robbins, T. W. (1996) · Journal of Psychopharmacology · doi:10.1177/026988119601000303 · Cited by 14
Self-citation
Cited by
Teleanu, R. I., Niculescu, A.-G., Roza, E., Vladâcenco, O., Grumezescu, A. M., & Teleanu, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115954 · Cited by 596
Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
Murley, A. G., Coyle-Gilchrist, I., Rouse, M. A., Jones, P. S., Li, W., Wiggins, J., Lansdall, C., Rodríguez, P. V., Wilcox, A., Tsvetanov, K. A., et al. (2020) · Brain · doi:10.1093/brain/awaa097 · Cited by 162
Self-citationFrontotemporal Dementia, Where Do We Stand? A Narrative Review
Antonioni, A., Raho, E. M., Lopriore, P., Pace, A. P., Latino, R. R., Assogna, M., Mancuso, M., Gragnaniello, D., Granieri, E., Pugliatti, M., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411732 · Cited by 145
Fluid biomarkers in frontotemporal dementia: past, present and future
Swift, I. J., Sogorb-Esteve, A., Heller, C., Synofzik, M., Otto, M., Graff, C., Galimberti, D., Todd, E., Heslegrave, A. J., van der Ende, E. L., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323520 · Cited by 122
Toward a glutamate hypothesis of frontotemporal dementia
Benussi, A., Alberici, A., Buratti, E., Ghidoni, R., Gardoni, F., Di Luca, M., Padovani, A., & Borroni, B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00304 · Cited by 90
“…could be reached by modulating (i) the immune system or (ii) the glutamatergic receptors, developing the latter approach in analogy to what has been demonstrated effective for Parkinson or Alzheimer disease, with dopaminergic and cholinergic therapies, respectively (Murley and Rowe, 2018).”
Background
Metadata
- Authors
- Murley, A. G., & Rowe, J. B.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-01-24
- Volume
- 141
- Issue
- 5
- Pages
- 1263-1285
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2790880291
- Cited by
- 202
- References
- 51
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.